Loading...
•
Mar 31, 2025
OraSure Q1 2025 Earnings Report
Reported financial results for the first quarter ended March 31, 2025
Key Takeaways
OraSure Technologies reported a significant decrease in total net revenues for Q1 2025, down 45% year-over-year, primarily driven by a 98% decline in COVID-19 revenues. Core business revenues saw a slight decrease of 2%. The company experienced increased GAAP and non-GAAP operating losses and net losses compared to the prior year.
Total net revenues decreased by 45% to $29.9 million in Q1 2025 compared to $54.1 million in Q1 2024, mainly due to lower COVID-19 revenues.
Core business revenues, excluding COVID-19 and Molecular Services, were $29.5 million, a 2% decrease year-over-year.
GAAP net loss for Q1 2025 was $16.0 million, or $(0.21) per share, compared to a net loss of $3.6 million, or $(0.05) per share, in Q1 2024.
The company ended the quarter with $248 million in cash and cash equivalents and authorized a $40 million stock repurchase program.
Revenue by Segment
Forward Guidance
For the second quarter of 2025, the company expects total revenues between $28.5 million and $32.5 million, with Core revenues in the range of $28 million to $32 million and approximately $0.5 million from COVID-19 and Risk Assessment testing revenues.
Positive Outlook
- Guiding to Q2 2025 revenues between $28.5 million and $32.5 million.
- Anticipating Core revenues in Q2 2025 of $28 million to $32 million.
Challenges Ahead
- Expects only approximately $0.5 million from COVID-19 and Risk Assessment testing revenues in Q2 2025.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...